EP-1761: Assessment of motion mitigation and setup monitoring in gating treatments with accelerated particles  by Pella, A. et al.
ESTRO 35 2016                                                                                                                                                    S825 
________________________________________________________________________________ 
4Yamaguchi University Graduate School of Medicine, 
Department of Therapeutic Radiology, Ube, Japan 
 
Purpose or Objective: Application of principal component 
analysis (PCA) to fiducial marker coordinate during 
respiratory cycle provides new axes including the first 
principal component (1st PC), which presents maximal 
motion direction. The purpose of this study is to investigate 
correlation of respiratory motion between the markers 
implanted in the lung and interfractional variation in 
directionality of the 1st PC. 
 
Material and Methods: Marker motion data in consecutive 9 
patients who had 4 or 5 gold fiducials implanted in the lung 
and received tumor-tracking stereotactic body radiotherapy 
in 4 fractions were analyzed. Superior–Inferior (SI)/ Left–
Right (LR)/ Anterior–Posterior (AP) positional data were 
acquired using a pair of orthogonal fluoroscopy in every 
fraction with the frame rate of 6.25 or 12.5 per second. 
Fifty-five datasets were eligible. The acquired SI/LR/AP 
coordinates were processed by PCA for each marker in all 
patients to calculate cumulative contribution ratio, principal 
component scores from 1st to 3rd PC and eigenvector of the 
1st PC. Motion amplitude was defined as the 95th percentile 
of 1st PC scores. We evaluated (1) contribution ratio (CR) of 
the 1st PC, (2) correlation of the 1st PC scores between 
different markers in each fraction and (3) angles formed by 
1st PC eigenvector of the first fraction and those of the 
others (defined as Ang1i (i=2, 3, 4)) for each marker. 
 
Results: Mean ± standard deviation (SD) of motion amplitude 
in the 1st PC direction was 20.2 ± 11 mm. Median 
contribution ratio (CR) of 1st PC was 0.933 (range: 0.721–
0.996). Median correlation coefficient of 1st PC score among 
the markers was 0.985 (range: 0.938–0. 999). For all markers, 
Ang1i varied from 1.19 to 23.3 degrees (deg) as shown in the 
Figure. Mean ± SD of Ang1i in 7 patients whose 1st PC 
directions seemed stable was 3.4 ± 1.03 deg, while 2 patients 
had larger variation (18.8 and 11.3 deg on average). The 
markers with larger interfractional variations in directionality 
had the tendency to be more affected by heartbeat or 
possess small motion amplitude with round shape orbit. 
 
 
 
Conclusion: The 1st PC of the marker coordinate during 
breathing generally provided a good explanation of its 
respiratory motion in the lung. Strong correlations in motion 
along the 1st PC direction between different markers were 
indicated. Interfractional variation in motion direction stayed 
small in most cases. 
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Purpose or Objective: The aim of this study is to evaluate 
the efficacy of motion mitigation tools in reducing 
respiration-induced target motion and to investigate the 
concordance of redundant breathing motion monitoring 
systems during gating treatments in radiotherapy with 
accelerated particles. 
 
Material and Methods: In our institution, a gating protocol 
for carbon ion therapy has been developed and since 2014 it 
is applied to lesions affected by non-negligible organ motion. 
It involves both abdominal compression (through tight 
thermoplastic body masks) and active beam rescanning. 4DCT 
is used to image anatomy variations between end-inspiration 
(EI) and end-expiration (EE) phases. Treatment is optimized 
on the EE phase and it is delivered in a gate-on window 
centered on it. Both 4DCT binning and gate-on trigger rely on 
the Anzai load cell system (Anzai Medical CO, LTD). To 
quantify the efficacy of abdominal compression, we 
evaluated the 3D GTV displacements observed between EE 
and EI phases of the planning 4DCT. A B-spline-based 
deformable registration algorithm was used to calculate the 
displacement field between EE and EI. GTV contours, as 
segmented in EE, were then propagated to the EI. In 
addition, an in-room optical tracking system (OTS) provided 
continuous breathing monitoring by localizing a set of surface 
markers. Each time the gating window was opened by the 
Anzai system, markers coordinates were stored and compared 
offline, in terms of 3D displacements, with the initial setup 
configuration. This solution allowed us to measure and 
quantify the intra-fraction concordance of surface 
surrogates.  
Data of six patients with thoracic and abdominal lesions has 
been evaluated. 
 
Results: A median (interquartile) 3D GTV displacement (EE-
EI) of 5.8 (2.0) mm, in a range of 1.4-10.9 mm, was observed. 
The maximum displacements (absolute values) were noticed 
in superior-inferior direction (range: 0.1-9.3 mm). Overall 
mean values of markers 3D displacements between setup 
conditions and data acquired during irradiation by the OTS 
were found to be lower than a millimeter (range: 0.1-0.7 
mm). We observed an intra-fractional significant difference 
among different irradiation fields, thus suggesting a small 
trend towards progressive deterioration of reproducibility 
during treatment delivery. 
 
Conclusion: Target 3D displacements, as calculated from the 
EE and EI phases, can be considered relevantly lower than 
those reported in literature for thoraco-abdominal lesions. 
These preliminary results suggest that patient’s respiratory 
pattern (and thus target trajectory) can often be reduced by 
means of appropriate immobilization/compression tools. 
During treatment delivery, sub-millimeter values of 3D 
discrepancies in surface surrogates detection demonstrate 
that the Anzai and the OTS operate consistently, therefore a 
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strategy combining these systems may increase set up control 
and motion monitoring robustness. 
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Purpose or Objective: To study the impact of breathing 
motion on proton breast treatment plans using scanned 
proton beams. 
 
Material and Methods: The study cohort was composed of 
twelve thoracic patients who had CT-datasets acquired 
during breath-hold at inhalation phase, breath-hold at 
exhalation phase and in free breathing mode. Proton 
treatment plans were designed for the left breast for the 
breath-hold at inhalation phase and were subsequently 
recalculated for the breath-hold at exhalation phase. 
Similarly, plans devised for the CT acquired in free breathing 
mode were recalculated for the extreme breath-hold phases. 
Four different field arrangements were used for each 
patient: two plans with three fields and two with one field. 
The dosimetric features of the plans were compared from the 
point of view of their coverage of the target and the doses to 
the organs at risk. 
 
Results: Breathing motion led to a degradation of the dose 
coverage of the target (heterogeneity index increased from 
about 6% to 8-11%). Exhalation tended to decrease the lung 
burden (average dose 3.1-4.2 GyRBE), while inhalation 
increased it (average dose 4.7-5.8 GyRBE). The absolute 
values depended on the field arrangement, but the trend was 
similar across the plans considered. Smaller differences in 
dosimetric parameters were seen for the heart (average dose 
0.1-0.2 GyRBE) and the left anterior descending artery (2.0-
4.0 GyRBE). The absolute values of the dosimetric 
parameters corresponding to various breathing phases were 
rather small and their expected clinical impact is therefore 
quite small. Furthermore, the plans parameters in either 
breathing phase were generally superior to the corresponding 
ones that could be achieved with photon plans. 
 
Conclusion: The results of this study indicated that the 
differences between the mean dosimetric parameters of the 
plans corresponding to the two extreme breathing phases are 
not significantly different, thus suggesting that breathing 
might have little impact for the chosen beam arrangements 
in proton scanned beam planning for breast cancer. Further 
investigations are needed to investigate the impact of 
interplay effects and whether the conclusions might be 
extended beyond the population considered in this study. 
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Purpose or Objective: In SBRT of lung lesions, respiratory 
motion is commonly considered by 4DCT imaging to define 
the internal target volume (ITV). Dose optimization is often 
performed on average CT using VMAT-based treatment 
techniques. However, average CT data ignores individual 
respiratory motion patterns during dose delivery and thus 
fluctuations in density distribution in the ITV. Additionally, 
interaction of MLC dose modulation and variable target 
motion might result in under-dosage of the target volume 
(interplay effect). This study analyses the efficiency of 
flattening filter free dose delivery and its impact on interplay 
effects in lung SBRT. 
 
Material and Methods: SBRT treatment plans were created 
for a lung tumor phantom using VMAT techniques employing 
the flattening filter (FF) and flattening filter free (FFF) mode 
(600MU and 1400MU per min). The phantom consists of a high 
resolution 2D detector array plus solid-water, bone, lung and 
tumor inserts. It is mounted on a 4D motion platform to 
simulate regular and irregular tumor motion trajectories 
extracted from clinical 4DCT data with max peak-to-peak 
amplitudes of 1.6/2.3cm in SI and 1.2/2.4cm in AP. The ITV 
includes a 2cm x 2cm lung tumor (CTV) plus 1.8cm safety 
margin in SI. Changes in dose distributions through interplay 
effects were investigated by analyzing static reference and 
dynamic dose measurements in FF and FFF mode at regular 
and irregular tumor motion using a planning structure-based 
evaluation method. 
 
Results: VMAT techniques in FF and FFF mode achieved 
almost identical dose distributions at static measurements 
(plan comparison). FFF allowed for approximately 40% shorter 
treatment time. For regular tumor motion (TM), FFF resulted 
in greater under- and over dosages of approximately 5-10% 
compared to FF in the CTV (cf. figure 1 for dose differences 
of dynamic and static measurements). However, 
corresponding γ-passing maps illustrate the increased 
interplay effect. Furthermore, FFF generated considerable 
under-dosages in the CTV in case of irregular TM. γ-passing 
rates (local γ of 3% / 1mm) decreased from 68% to 62% for 
regular TM and 41% to 34% for irregular TM within the ITV (cf. 
figure 1). Dose area histograms for CTV and ITV 
complementarily confirm above changes in dose differences 
and γ-maps. 
 
 
 
Conclusion: FFF dose delivery in lung SBRT provides shorter 
treatment times. However, the risk of interplay effects is 
increased, in particular for irregular tumor motion. Further 
